Carlos G. Gonzalez

3.6k total citations · 2 hit papers
27 papers, 2.1k citations indexed

About

Carlos G. Gonzalez is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Carlos G. Gonzalez has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Carlos G. Gonzalez's work include Gut microbiota and health (15 papers), Clostridium difficile and Clostridium perfringens research (10 papers) and Gastrointestinal motility and disorders (4 papers). Carlos G. Gonzalez is often cited by papers focused on Gut microbiota and health (15 papers), Clostridium difficile and Clostridium perfringens research (10 papers) and Gastrointestinal motility and disorders (4 papers). Carlos G. Gonzalez collaborates with scholars based in United States, United Kingdom and Tanzania. Carlos G. Gonzalez's co-authors include Joshua E. Elias, Justin L. Sonnenburg, Erica D. Sonnenburg, Bryan D. Merrill, Dylan Dahan, Feiqiao Brian Yu, Christopher D. Gardner, Rob Knight, Madeline A. Topf and Hannah C. Wastyk and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Carlos G. Gonzalez

25 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut-microbiota-targeted diets modulate human immune status

2021 790 citations Hannah C. Wastyk, Gabriela K. Fragiadakis et al. Cell profile →
Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania

2017 567 citations Erica D. Sonnenburg, Carlos G. Gonzalez et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlos G. Gonzalez United States	13	1.5k	503	455	298	240	27	2.1k
Charisse Petersen Canada	21	1.7k 1.1×	490 1.0×	466 1.0×	243 0.8×	234 1.0×	40	2.7k
Naomi Hotte Canada	23	1.5k 1.0×	511 1.0×	443 1.0×	207 0.7×	287 1.2×	51	2.6k
Chuanxing Xiao China	17	1.9k 1.3×	435 0.9×	617 1.4×	255 0.9×	189 0.8×	43	2.8k
Lisa Maier Germany	17	1.8k 1.2×	724 1.4×	465 1.0×	491 1.6×	332 1.4×	40	3.0k
Qiang Feng China	24	1.2k 0.8×	293 0.6×	452 1.0×	223 0.7×	174 0.7×	78	2.3k
Ashwana D. Fricker United States	9	1.8k 1.2×	447 0.9×	457 1.0×	335 1.1×	247 1.0×	14	2.4k
Samuel A. Smits United States	9	2.0k 1.3×	559 1.1×	723 1.6×	384 1.3×	260 1.1×	11	2.5k
Mihaela Pruteanu Germany	13	1.6k 1.1×	456 0.9×	367 0.8×	238 0.8×	360 1.5×	15	2.1k
Jessica D. Forbes Canada	16	1.2k 0.8×	406 0.8×	278 0.6×	205 0.7×	297 1.2×	30	1.9k
Doris Vandeputte Belgium	12	1.9k 1.3×	426 0.8×	682 1.5×	400 1.3×	218 0.9×	20	2.6k

Countries citing papers authored by Carlos G. Gonzalez

Since Specialization

Citations

This map shows the geographic impact of Carlos G. Gonzalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos G. Gonzalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos G. Gonzalez more than expected).

Fields of papers citing papers by Carlos G. Gonzalez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos G. Gonzalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos G. Gonzalez. The network helps show where Carlos G. Gonzalez may publish in the future.

Co-authorship network of co-authors of Carlos G. Gonzalez

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos G. Gonzalez. A scholar is included among the top collaborators of Carlos G. Gonzalez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos G. Gonzalez. Carlos G. Gonzalez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lim, Bentley, Jinghua Xu, Igor H. Wierzbicki, et al.. (2025). A human gut bacterium antagonizes neighboring bacteria by altering their protein-folding ability. Cell Host & Microbe. 33(2). 200–217.e24. 4 indexed citations

Knapp, Benjamin D., Lisa Willis, Carlos G. Gonzalez, et al.. (2024). Metabolic rearrangement enables adaptation of microbial growth rate to temperature shifts. Nature Microbiology. 10(1). 185–201. 9 indexed citations

Gonzalez, Carlos G., Toer Stevens, Bram Verstockt, et al.. (2024). Crohn’s Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab. Inflammatory Bowel Diseases. 30(9). 1536–1545.

Dorman, Leah C., Sudip Khadka, Ryan Ward, et al.. (2024). BiP/GRP78 is a pro-viral factor for diverse dsDNA viruses that promotes the survival and proliferation of cells upon KSHV infection. PLoS Pathogens. 20(10). e1012660–e1012660. 2 indexed citations

Blount, Ken, et al.. (2024). Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTA) for Preventing Recurrent Clostridioides difficile Infection. The Journal of Infectious Diseases. 231(6). e1022–e1033. 5 indexed citations

Smith, Emma, Paola Leone, Gerold Bongers, et al.. (2023). Oral vancomycin treatment suppresses gut trypsin activity and preserves intestinal barrier function during EAE. iScience. 26(11). 108143–108143. 4 indexed citations

Gonzalez, Carlos G., Robert H. Mills, Qiyun Zhu, et al.. (2022). Location-specific signatures of Crohn’s disease at a multi-omics scale. Microbiome. 10(1). 133–133. 44 indexed citations

Aranda-Díaz, Andrés, Katharine M. Ng, Dylan Dahan, et al.. (2022). Establishment and characterization of stable, diverse, fecal-derived in vitro microbial communities that model the intestinal microbiota. Cell Host & Microbe. 30(2). 260–272.e5. 62 indexed citations

Blount, Ken, et al.. (2022). Development and Validation of a Novel Microbiome-Based Biomarker of Post-antibiotic Dysbiosis and Subsequent Restoration. Frontiers in Microbiology. 12. 781275–781275. 15 indexed citations

10.

Wastyk, Hannah C., Gabriela K. Fragiadakis, Dalia Perelman, et al.. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell. 184(16). 4137–4153.e14. 790 indexed citations breakdown →

11.

Shi, Handuo, Corey S. Westfall, Pascal D. Odermatt, et al.. (2021). Starvation induces shrinkage of the bacterial cytoplasm. Proceedings of the National Academy of Sciences. 118(24). 43 indexed citations

12.

Shi, Handuo, Yan Hu, Pascal D. Odermatt, et al.. (2021). Precise regulation of the relative rates of surface area and volume synthesis in bacterial cells growing in dynamic environments. Nature Communications. 12(1). 1975–1975. 36 indexed citations

13.

Blount, Ken, et al.. (2021). 1064. Treatment Success in Reducing Recurrent Clostridioides difficile Infection with Investigational Live Biotherapeutic RBX2660 Is Associated with Microbiota Restoration: Consistent Evidence from a Phase 3 Clinical Trial. Open Forum Infectious Diseases. 8(Supplement_1). S624–S625. 8 indexed citations

14.

Khanna, Sahil, Darrell S. Pardi, Courtney Jones, et al.. (2020). RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections. Clinical Infectious Diseases. 73(7). e1613–e1620. 39 indexed citations

15.

Gonzalez, Carlos G., et al.. (2019). Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitors. Scientific Reports. 9(1). 12460–12460. 8 indexed citations

16.

Zhang, Lichao, Kavya Swaminathan, Carlos G. Gonzalez, et al.. (2019). TagGraph reveals vast protein modification landscapes from large tandem mass spectrometry datasets. Nature Biotechnology. 37(4). 469–479. 99 indexed citations

17.

Tropini, Carolina, Eli L. Moss, Bryan D. Merrill, et al.. (2018). Transient Osmotic Perturbation Causes Long-Term Alteration to the Gut Microbiota. Cell. 173(7). 1742–1754.e17. 171 indexed citations

18.

Gonzalez, Carlos G. & Nehad Shabarek. (2014). Community acquired methicillin sensitive Staphylococcus aureus bacteremia, meningitis and brain abscess: A unique presentation. International Journal of Case Reports and Images. 5. 1–1. 1 indexed citations

19.

Feghaly, Rana E. El, Jennifer L. Stauber, Elena Deych, et al.. (2013). Markers of Intestinal Inflammation, Not Bacterial Burden, Correlate With Clinical Outcomes in Clostridium difficile Infection. Clinical Infectious Diseases. 56(12). 1713–1721. 137 indexed citations

20.

Gonzalez, Carlos G., et al.. (1999). No man is an island; no island is an island: does the immune network extend beyond the limits of skin?. Medical Hypotheses. 52(4). 325–327. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact